Cell Therapy for Patients with Amyotrophic Lateral Sclerosis Shows Promise in Human Trials

Cell therapy for patients with amyotrophic lateral sclerosis shows promise in human trials

Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, has invented a new cell therapy that shows strong promise for the treatment of amyotrophic lateral sclerosis (ALS), aplastic anemia and other devastating diseases.

Texas A&M Inventor Turns Breakthrough Cell Therapy Into Hope for Patients with ALS and other Devastating Diseases

BRYAN-COLLEGE STATION, Texas – Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, has invented a new cell therapy that shows strong promise for the treatment of ALS, aplastic anemia and other devastating diseases. Her therapy has been evaluated in dozens of human patients and has been shown to be safe and, to date, effective. “I…